<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134569">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02012179</url>
  </required_header>
  <id_info>
    <org_study_id>MOP130275</org_study_id>
    <nct_id>NCT02012179</nct_id>
  </id_info>
  <brief_title>SODIUM-HF: Study of Dietary Intervention Under 100 MMOL in Heart Failure</brief_title>
  <acronym>SODIUM-HF</acronym>
  <official_title>The Long Term Effects of Dietary Sodium Restriction on Clinical Outcomes in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <authority>Canada: Canadian Institutes of Health Research</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      SODIUM-HF is a multicenter clinical trial in ambulatory patients with chronic HF to evaluate
      the efficacy of a low sodium containing diet on a composite clinical outcome composed of of
      all-cause mortality, cardiovascular hospitalizations and cardiovascular emergency department
      visits.

      The hypothesis of this study is that patients following a low-sodium containing diet will
      have fewer clinical events (fewer hospital readmissions or emergency department visits,
      longer survival) than those on Usual Care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Composite Clinical Outcomes</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>All-cause mortality, cardiovascular hospitalizations or cardiovascular emergency department visits</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exercise capacity</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in exercise capacity as measured by the 6-minute walk test (6MWT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA functional class</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in NYHA class treated as a categorical variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in quality of life assessed by the KCCQ</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Low sodium diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low sodium diet (65 mmol or 1500 mg/day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>General advice to limit dietary sodium as it is provided during routine clinic practice</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low sodium diet</intervention_name>
    <description>Low sodium diet (65 mmol or 1500 mg/day)</description>
    <arm_group_label>Low sodium diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients recruited if they are 18+ years or older, with confirmed diagnosis of HF
             (both reduced and preserved systolic function are eligible), NYHA class II-III, and
             willing to sign informed consent.

        Exclusion Criteria:

        Subjects will be excluded if:

          -  Average dietary intake of &lt;1500 mg/ day by a quantitative or semi-quantitative method

          -  Serum sodium &lt;130mmol/L

          -  Renal failure (glomerular filtration rate &lt;30 mL/min)

          -  Hepatic failure

          -  Uncontrolled thyroid disorder

          -  Cardiac device (ICD or CRT) or revascularization procedure (PCI or CABG) in previous
             month or planned in next 3 months

          -  Hospitalization due to cardiovascular causes in previous 1 month

          -  Uncontrolled atrial fibrillation (resting heart rate &gt;90 bpm)

          -  Active malignancy

          -  Moderate-severe dementia

          -  Enrolled in another interventional research study

          -  Patients will be excluded, if in the opinion of the investigator, another condition
             exists that would preclude dietary compliance or compliance with the protocol.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justin Ezekowitz, MBBCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eloisa Colin, PhD</last_name>
    <email>sodiumhf@ualberta.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Justin Ezekowitz, MBBCh</last_name>
    <email>sodiumhf@ualberta.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eloisa Colin, PhD</last_name>
      <email>sodiumhf@ualberta.ca</email>
    </contact>
    <investigator>
      <last_name>Justin Ezekowitz, MBBCh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>sodiumhf@ualberta.ca</email>
    </contact>
    <investigator>
      <last_name>Mustafa Toma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 14, 2014</lastchanged_date>
  <firstreceived_date>December 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diet</keyword>
  <keyword>Dietary sodium reduction</keyword>
  <keyword>Salt restriction</keyword>
  <keyword>Nutrition</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
